Compugen Publishes Paper in Cancer Immunology Research on Unique Biology of PVRIG and its Therapeutic Potential
Go back to Compugen Publishes Paper in Cancer Immunology Research on Unique Biology of PVRIG and its Therapeutic Potential| Compugen Ltd (NASDAQ: CGEN) | Delayed: 2.08 +0.07 (3.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.01 | 52 Week High | $7.79 | |||
| Open | $2.02 | 52 Week Low | $4.32 | |||
| Day High | $2.10 | P/E | N/A | |||
| Day Low | $2.02 | EPS | $-0.36 | |||
| Volume | 141,221 | |||||
| Compugen Ltd (NASDAQ: CGEN) | Delayed: 2.08 +0.07 (3.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.01 | 52 Week High | $7.79 | |||
| Open | $2.02 | 52 Week Low | $4.32 | |||
| Day High | $2.10 | P/E | N/A | |||
| Day Low | $2.02 | EPS | $-0.36 | |||
| Volume | 141,221 | |||||

